Gabify, a health-tech startup focused on addressing neurodevelopmental challenges in children, has raised $175,000 in a pre-seed funding round led by Inflection Point Ventures (IPV). In addition to the investment, the company has also been awarded ?25 lakhs under the NIDHI Seed Support Scheme by GHRTBI (G H Raisoni Technology Business Incubator Foundation), a government-backed initiative that supports early-stage, innovation-driven startups.
The funds will be used to advance clinical validation, enhance its technology platform, and expand the team which is said to be the key steps towards scaling operations and building a sustainable revenue model.
A part of the 4th cohort of IPV IdeaSchool-a cohort-based incubator program for early-stage startups-Gabify joins a growing network of ventures that have received structured mentorship and funding support through the initiative.
Positioned as India’s first fully hosted SaaS ecosystem for speech and neurodevelopmental therapy, Gabify combines advanced AI technologies to streamline screening and treatment for disorders such as Autism and ADHD.
Its dual-AI engine powered by both voice and vision analyzes children’s speech, facial expressions, eye gaze, and behavioural patterns using more than 189 clinically validated parameters aligned with DSM-5 and CARS guidelines.
To ensure reliability, the model employs a human-in-the-loop (HITL) system where professionals review AI-generated outcomes before final assessments.
Built with inclusivity in mind, Gabify’s multilingual, low-bandwidth architecture makes it suitable even for rural and remote communities across Bharat, with strong global scalability potential. The platform is designed to reduce assessment time by up to 70%, helping clinicians manage more patients without compromising accuracy or care quality.
Gabify’s private beta has already been tested across 35+ preschools and daycare centres in India. The platform is now being adopted by schools, hospitals, private clinics, and NGOs.
Internationally, Gabify has gained recognition through programs like UNDP Youth Co:Lab, SISF Grant, and global events such as the Madrid International Conference solidifying its reputation as a fast-emerging name in digital neurotherapy. The company aims to impact one million children by 2028 through its B2B, B2C, and CSR partnerships.
Behind Gabify is an experienced founding team with diverse expertise across business, clinical therapy, and technology.
Founder & CEO Sahil Chopra brings over 12 years of startup leadership experience, while Co-founder & Chief Medical Officer Prachi Sood is a seasoned speech therapist who has worked with leading hospitals such as Max and Fortis.
Co-founder & CTO Vasyl Leshchuk brings a global perspective with over 15 years in AI, cybersecurity, and large-scale tech systems at CIENCE and Freightos.
Gabify’s innovation has been widely recognized. It was named among the Top 10 Startups by DreamDeal, an initiative by Anupam Mittal, CEO of People Group and has received multiple accolades, including the Startup Rajasthan Ratna Award from MeitY, Government of India, for its role in advancing digital health innovation.
The startup has also won the OCP Challenge 1.0, topped the Saksham Accelerator by SACC India at TiEcon Chandigarh, and represented India globally as a finalist at the UNDP and Citi Foundation’s Youth Co:Lab.
With a global market opportunity estimated at USD 110 billion and growing at nearly 15% annually, Gabify aims to stand at the forefront of a sector driven by rising autism prevalence, increasing AI adoption in healthcare, and the worldwide need for digital-first early-intervention tools.
Leadership Comment
Commenting on the fund raise, Ankur Mittal, Co-founder, Inflection Point Ventures, says, “Addressing neurodevelopmental challenges at an early stage plays a critical role in shaping a child’s future, yet it remains one of the most underserved areas in the healthcare ecosystem. Gabify is tackling this gap through a strong blend of clinical validation and AI-led innovation, enabling faster and more accurate identification of developmental conditions.”
“Their approach has the potential to significantly reduce diagnosis timelines, improve intervention outcomes, and expand access to quality care for families and clinicians alike. At Inflection Point Ventures, we are excited to support Gabify as they work toward transforming early detection and intervention pathways through scalable, technology-driven solutions, both in India and globally. We look forward to leveraging our network and strategic expertise to help the company accelerate its growth journey, continued Ankur Mittal.”
Sahil Chopra, Founder & CEO, Gabify says, “Working with Inflection Point Ventures has been a deeply collaborative experience. Beyond capital, IPV brings strategic insight, credibility, and a strong founder-first mindset. Our goal with Gabify is to ensure that no child is left behind simply due to delayed diagnosis or lack of access. We are building technology that empowers clinicians, supports parents, and gives every child a fair chance at early intervention and a better future.”
